Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study

Factor Inhibitor ◽

Necrosis Factor ◽

The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor- inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China

Rheumatology ◽

10.1093/rheumatology/ker087 ◽

2011 ◽

Vol 50 (8) ◽

pp. 1466-1472 ◽

Cited By ~ 23

Author(s):

M. Xu ◽

Z. Lin ◽

X. Deng ◽

L. Li ◽

Y. Wei ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Disease Activity Score ◽

Activity Score ◽

Factor Inhibitor ◽

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor

10.1136/annrheumdis-2012-201999 ◽

2012 ◽

Vol 71 (12) ◽

pp. 2002-2005 ◽

Cited By ~ 60

Author(s):

Pedro Machado ◽

Robert B M Landewé ◽

Jürgen Braun ◽

Xenofon Baraliakos ◽

Kay-Geert A Hermann ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Clinical Disease ◽

Clinical Disease Activity ◽

Factor Inhibitor ◽

Treatment Responses ◽

FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study

10.1136/annrheumdis-2017-eular.4787 ◽

2017 ◽

Author(s):

J Rech ◽

M Hagen ◽

M Englbrecht ◽

J Haschka ◽

M Reiser ◽

...

Keyword(s):

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Sustained Remission ◽

Randomized Controlled ◽

Factor Inhibitor ◽

Tumour necrosis factor inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients

10.1136/ard.2002.004226 ◽

2004 ◽

Vol 63 (3) ◽

pp. 318-320 ◽

Cited By ~ 77

Author(s):

C Pritchard

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Secukinumab in patients with psoriasis who have responded inadequately to tumour necrosis factor inhibitor treatment

British Journal of Dermatology ◽

10.1111/bjd.18869 ◽

2020 ◽

Vol 183 (1) ◽

pp. 7-8

Author(s):

T.‐F. Tsai

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

10.1136/annrheumdis-2015-208490 ◽

2015 ◽

Vol 75 (4) ◽

pp. 785-786 ◽

Cited By ~ 18

Author(s):

L Dreyer ◽

M Magyari ◽

B Laursen ◽

R Cordtz ◽

F Sellebjerg ◽

...

Keyword(s):

Multiple Sclerosis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Population Based Study ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry

10.1136/annrheumdis-2012-201319 ◽

2012 ◽

Vol 72 (1) ◽

pp. 57-63 ◽

Cited By ~ 23

Author(s):

Lykke Midtbøll Ørnbjerg ◽

Mikkel Østergaard ◽

Pernille Bøyesen ◽

Niels Steen Krogh ◽

Anja Thormann ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Radiographic Progression ◽

Factor Inhibitor ◽

Necrosis Factor ◽

248 Sustained improvements in disease activity for up to two-years with ixekizumab in patients with active psoriatic arthritis who were either biologic-naïve or with previous inadequate response to tumour necrosis factor inhibitor therapy

Rheumatology ◽

10.1093/rheumatology/kez107.064 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Author(s):

Deepak R Jadon ◽

Mani Haschemi Nassab ◽

Katrien Van Beneden ◽

Georg Pum ◽

Andrew J Bradley

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Inadequate Response ◽

Factor Inhibitor ◽

OP0289 Comorbidity with Depression and Anxiety is Associated with Discontinuation of Tumour Necrosis Factor Inhibitor (TNFI) Therapy in Ankylosing Spondylitis (AS)

10.1136/annrheumdis-2015-eular.4533 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 181.3-182

Author(s):

E. Lie ◽

U. Lindström ◽

L.E. Kristensen ◽

H. Forsblad-d'Elia ◽

J. Askling ◽

...

Keyword(s):

Ankylosing Spondylitis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Depression And Anxiety ◽

Factor Inhibitor ◽

I122. REAL-WORLD EFFECTIVENESS OF TUMOUR NECROSIS FACTOR INHIBITOR IN ANKYLOSING SPONDYLITIS

Rheumatology ◽

10.1093/rheumatology/kex060.122 ◽

2017 ◽

Vol 56 (suppl_2) ◽

Author(s):

Gareth T. Jones

Keyword(s):

Ankylosing Spondylitis ◽

Tumour Necrosis Factor ◽

Real World ◽

Tumour Necrosis ◽

Factor Inhibitor ◽